Suppr超能文献

评估终止高血压膳食方法饮食与热量限制饮食对代谢功能障碍相关脂肪性肝病的影响:一项随机对照试验的荟萃分析。

Evaluating the impact of the Dietary Approaches to Stop Hypertension diet versus a calorie-restricted diet on metabolic dysfunction-associated steatotic liver disease: A meta-analysis of randomized controlled trials.

作者信息

Hasan Fariha, Singh Avneet, Garcia Alexander, Qadri Syeda Hafsa, Sattar Hina, Ali Rimmel, Ali Hassam, Nguyen Tommy, Mohan Babu P, Contino Krysta

机构信息

Department of Internal Medicine, Cooper University Hospital, Camden, New Jersey, USA.

Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.

出版信息

Hepatol Res. 2025 Apr;55(4):515-526. doi: 10.1111/hepr.14155. Epub 2024 Dec 26.

Abstract

AIM

Metabolic dysfunction-associated steatotic liver disease (MASLD) can lead to increased morbidity and mortality. Diets high in refined carbohydrates and saturated fats elevate MASLD risk. The Dietary Approaches to Stop Hypertension (DASH) diet has shown metabolic benefits. This meta-analysis evaluates the impact of the DASH diet on MASLD progression.

METHODS

A systematic search from 2016 to 2023 across PubMed, Embase, Web of Science, and Cochrane databases was conducted to identify studies reporting on the role of the DASH diet in MASLD. Standard meta-analysis methods were employed using a random-effects model. Heterogeneity was assessed by I statistics.

RESULTS

We identified five randomized controlled trials meeting inclusion criteria, involving 280 participants (140 in the DASH group and 140 in the control group). Mean ages were approximately 41 years, and the proportions of women were similar between groups. Compared with controls, the DASH diet group had a significantly reduced risk of grade 0 and 1 liver fibrosis (RR 1.21, 95% CI 1.04-1.41, p = 0.01). They also showed lower levels of aspartate aminotransferase (MD -4.81, 95% CI -6.98 to -2.64, p < 0.0001), alanine aminotransferase (MD -10.31, 95% CI -13.82 to -6.80, p < 0.00001), body mass index (MD -0.74, 95% CI -1.45 to -0.03, p = 0.04), and cholesterol-to-high-density lipoprotein ratio (MD -0.40, 95% CI -0.68 to -0.11, p = 0.006). No significant differences were found for weight, waist and hip circumference, total cholesterol, low-density lipoprotein, or high-density lipoprotein levels. Heterogeneity was low for most outcomes (I = 0%).

CONCLUSION

Based on our meta-analysis of five randomized controlled trials, the DASH diet may reduce MASLD progression. These findings suggest it could be an effective dietary intervention for MASLD management.

摘要

目的

代谢功能障碍相关脂肪性肝病(MASLD)可导致发病率和死亡率增加。高糖和饱和脂肪饮食会增加患MASLD的风险。终止高血压膳食疗法(DASH饮食)已显示出代谢益处。本荟萃分析评估DASH饮食对MASLD进展的影响。

方法

对2016年至2023年期间在PubMed、Embase、科学网和Cochrane数据库中进行的系统检索,以确定报告DASH饮食在MASLD中作用的研究。采用标准荟萃分析方法,使用随机效应模型。通过I统计量评估异质性。

结果

我们确定了五项符合纳入标准的随机对照试验,涉及280名参与者(DASH组140名,对照组140名)。平均年龄约为41岁,两组女性比例相似。与对照组相比,DASH饮食组0级和1级肝纤维化风险显著降低(风险比1.21,95%置信区间1.04 - 1.41,p = 0.01)。他们的天冬氨酸转氨酶水平也较低(平均差 - 4.81,95%置信区间 - 6.98至 - 2.64,p < 0.0001),丙氨酸转氨酶(平均差 - 10.31,95%置信区间 - 13.82至 - 6.80,p < 0.00001),体重指数(平均差 - 0.74,95%置信区间 - 1.45至 - 0.03,p = 0.04),以及胆固醇与高密度脂蛋白比值(平均差 - 0.40,95%置信区间 - 0.68至 - 0.11,p = 0.006)。在体重、腰围和臀围、总胆固醇、低密度脂蛋白或高密度脂蛋白水平方面未发现显著差异。大多数结果的异质性较低(I = 0%)。

结论

基于我们对五项随机对照试验的荟萃分析,DASH饮食可能会减缓MASLD的进展。这些发现表明,它可能是一种有效的饮食干预措施,用于管理MASLD。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验